Groundbreaking Study Identifies Genetic Variants Linked to Radiation Sensitivity in Prostate Cancer Patients

A new study has made a significant breakthrough in the field of prostate cancer treatment by identifying genetic variants that make some patients more sensitive to radiation in specific parts of the rectum. Led by University of Manchester scientists, the research combined genetic data with detailed spatial maps of where radiation is delivered in the rectum, providing a more personalized approach to prostate cancer treatment. The study analyzed data from 1,293 prostate cancer patients as part of the international REQUITE study, which collected radiotherapy outcomes from 17 hospitals in Europe and the USA between 2014 and 2016.

Key Takeaways:

• The study identified genetic variants that make some patients more sensitive to radiation in specific parts of the rectum, reducing the risk of severe bowel complications from radiotherapy, known as rectal toxicity.
• The research is the first to combine genetic data with detailed spatial maps of where radiation is delivered in the rectum, providing a more personalized approach to prostate cancer treatment.
• The study analyzed data from 1,293 prostate cancer patients as part of the international REQUITE study, which collected radiotherapy outcomes from 17 hospitals in Europe and the USA between 2014 and 2016.
• The researchers used a special way of analyzing 3D image data by looking at it in tiny volume units called voxels, which allowed them to identify smaller regions of organs where more radiation dose is linked to different treatment side-effects.
• The findings suggest that patients with certain genetic variants may benefit from lower radiation doses in specific parts of the rectum, which could make a significant difference to their recovery.
• The study's lead researcher, PhD researcher Artemis Bouzaki, stated that "rectal toxicity is a significant concern for patients receiving radiotherapy for prostate cancer, the most common cancer in men and now the most common cancer in England.

Statistics:

• 1,293 patients were analyzed in the study as part of the international REQUITE study.
• 17 hospitals in Europe and the USA contributed to the study between 2014 and 2016.
• The study found that genetic variants can make patients more sensitive to radiation in specific parts of the rectum.
• The risk regions were consistently in the lower posterior rectum.

Sources:

• University Of Manchester
• Prostate Cancer UK
• REQUITE study
• Contify.com